Trial intelligence / Profile preview

Enteral Nutrition in Esophageal Squamous Cell Carcinoma Chemoradiotherapy

NCT02399306Phase 3Completed

Sponsor
Sichuan Cancer Hospital
Start
Sep 2014
Primary completion
Oct 2017
Countries
1
01

Overview

Phase 3, randomised, open-label trial (2 arms), sponsored by Sichuan Cancer Hospital. Primary endpoint: Body Weight Change from baseline to the end of treatment. Started Sep 2014; status: completed.

Beyond the preview

Go deeper on NCT02399306.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02399306.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call